ProQR Therapeutics N.V
ProQR Therapeutics N.V (PRQR) Straddle
PRQR straddle scan found 10 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 70.9%.
Read more
Trading a PRQR straddle lets you take a pure volatility position on ProQR Therapeutics N.V without committing to a direction. ProQR Therapeutics N.V's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate PRQR straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on PRQR profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when ProQR Therapeutics N.V stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the PRQR straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clinical trial to treat USH2A-mediated retinitis pigmentosa and usher syndrome. The company also engages in the developing of Axiomer RNA base-editing platform technology. It has a license agreement with Radboud University Medical Center, Inserm Transfert SA, Ionis Pharmaceuticals, Inc., and Leiden University Medical Center, as well as license and research collaboration with Eli Lilly and Company for the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system.
ProQR Therapeutics N.V. was incorporated in 2012 and is headquartered in Leiden, the Netherlands.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the PRQR straddle is the cleanest expression of that view. Our scanner prices every PRQR straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a PRQR straddle into a catalyst or short a PRQR straddle to harvest decay, the options straddle setups that matter are all in one place.
| Apr 16, 2027 | 7.50 | $5.98 | 206 | 20% | 70.9% | $13.48 | $1.53 | 0 |
| Dec 18, 2026 | 2.00 | $0.88 | 87 | 20% | 61.8% | $2.88 | $1.13 | 0 |
| Apr 16, 2027 | 5.00 | $3.98 | 206 | 20% | 61.7% | $8.98 | $1.03 | 0 |
| Jan 15, 2027 | 5.00 | $3.60 | 115 | 20% | 60.0% | $8.60 | $1.40 | 0 |
| Apr 16, 2027 | 2.50 | $1.80 | 206 | 20% | 57.3% | $4.30 | $0.70 | 0 |
| Jan 15, 2027 | 2.50 | $1.58 | 115 | 20% | 52.0% | $4.08 | $0.93 | 5 |
| Nov 20, 2026 | 1.50 | $0.70 | 59 | 20% | 49.0% | $2.20 | $0.80 | 0 |
| Jan 15, 2027 | 2.00 | $1.33 | 115 | 20% | 44.6% | $3.33 | $0.68 | 1 |
| Apr 16, 2027 | 2.00 | $1.65 | 206 | 20% | 40.5% | $3.65 | $0.35 | 0 |
| Apr 16, 2027 | 1.50 | $1.50 | 206 | 20% | 15.9% | $3.00 | $0.00 | 0 |
As of September 23, 2026
Find the right straddle before volatility moves
Track PRQR straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.
Start your 14-day free trial→